Intensity-modulated radiation therapy (IMRT) in combination with fluzoparib, abiraterone acetate tablets (II), and prednisone.
FirstHCMU-JBi-PARTOM
Phase 2 small_molecule active
Quick answer
Intensity-modulated radiation therapy (IMRT) in combination with fluzoparib, abiraterone acetate tablets (II), and prednisone. for Metastatic Castration-resistant Prostate Cancer is a Phase 2 program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Metastatic Castration-resistant Prostate Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active